u 77779 has been researched along with sjg 136 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alley, MC; Gregson, SJ; Hartley, JA; Hollingshead, MG; Howard, PW; Pacula-Cox, CM; Sausville, EA; Thurston, DE; Waud, WR | 1 |
1 other study(ies) available for u 77779 and sjg 136
Article | Year |
---|---|
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 2: efficacy evaluations.
Topics: Animals; Antineoplastic Agents; Benzodiazepines; Benzodiazepinones; Cell Line, Tumor; Cross-Linking Reagents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Screening Assays, Antitumor; Duocarmycins; Humans; Indoles; Mice; Mice, Nude; Pyrroles; Rats; Rats, Nude; Urea; Xenograft Model Antitumor Assays | 2004 |